Bausch + Lomb Corporation (BLCO)

USD 12.6

(4.52%)

Long Term Debt Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual long term debt in 2023 was 4.53 Billion USD , up 87.97% from previous year.
  • Bausch + Lomb Corporation's latest quarterly long term debt in 2024 Q3 was 4.59 Billion USD , down -0.07% from previous quarter.
  • Bausch + Lomb Corporation reported annual long term debt of 2.41 Billion USD in 2022, up 2520.65% from previous year.
  • Bausch + Lomb Corporation reported annual long term debt of 92 Million USD in 2021, up 10.84% from previous year.
  • Bausch + Lomb Corporation reported quarterly long term debt of 4.6 Billion USD for 2024 Q2, up 1.05% from previous quarter.
  • Bausch + Lomb Corporation reported quarterly long term debt of 4.55 Billion USD for 2024 Q1, up 0.49% from previous quarter.

Annual Long Term Debt Chart of Bausch + Lomb Corporation (2023 - 2019)

Historical Annual Long Term Debt of Bausch + Lomb Corporation (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 4.53 Billion USD 87.97%
2022 2.41 Billion USD 2520.65%
2021 92 Million USD 10.84%
2020 83 Million USD 7.79%
2019 77 Million USD 0.0%

Peer Long Term Debt Comparison of Bausch + Lomb Corporation

Name Long Term Debt Long Term Debt Difference
Alcon Inc. 4.59 Billion USD 1.316%
AptarGroup, Inc. 726.45 Million USD -523.851%
Baxter International Inc. 11.06 Billion USD 59.038%
Becton, Dickinson and Company 14.73 Billion USD 69.25%
Haemonetics Corporation 797.56 Million USD -468.23%
Envista Holdings Corp 1.5 Billion USD -200.531%
ResMed Inc. 697.31 Million USD -549.923%
Teleflex Incorporated 1.83 Billion USD -146.455%
Warby Parker Inc. 150.17 Million USD -2917.893%
West Pharmaceutical Services, Inc. 157.3 Million USD -2781.119%